Product Information
EVEROLIMUS 0.5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $3.6886 per EA under NDC 51991038006. Its NADAC has been published 155 times since Jul 12, 2023.
Strength
.5 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991038006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA205432On Market Since
5/21/2021
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.5 MG TABLET has been published 155 times since Jul 12, 2023, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6886 per EA |
|---|---|
| All-time high | $10.1199 (Apr 10, 2024) |
| All-time low | $3.6048 (May 20, 2026) |
| 52-week high | $4.9030 |
| 52-week low | $3.6048 |
| Median price | $4.8089 |
| Average price | $5.2236 |
| Largest weekly change | +47.4% (Mar 20, 2024) |
| Weeks tracked | 155 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $3.6886 per EA (NDC 51991038006), effective Jun 24, 2026.
How has the price of EVEROLIMUS 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.5 MG TABLET has declined 27.3%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.5 MG TABLET?
Since Jul 12, 2023, the NADAC for EVEROLIMUS 0.5 MG TABLET has ranged from a low of $3.6048 (May 20, 2026) to a high of $10.1199 (Apr 10, 2024), with a median of $4.8089 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as EVEROLIMUS 0.5 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.5 MG TABLET?
EVEROLIMUS 0.5 MG TABLET (NDC 51991038006) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification